Working to develop the first orally administered integrin therapeutics for patients with immunological, fibrotic, neoplastic, and vascular diseases.
Small Molecules, vision and ocular related diseases, and Huntington's disease treatments
The company works on technologies to treat lupus and Sjögren’s disease byremoving inflammatory molecules. Develops Fc - nuclease fusion proteins.
ZymoGenetics is focused on the discovery and early manufacture of therapeutic proteins.